Works by Nakamura, Yoichi


Results: 138
    1
    2
    3
    4
    5
    6
    7
    8

    Prophylactic antibiotics given within 24 hours of surgery, compared with antibiotics given for 72 hours perioperatively, increased the rate of methicillin-resistant Staphylococcus aureus isolated from surgical site infections.

    Published in:
    Journal of Infection & Chemotherapy (Springer Science & Business Media B.V.), 2008, v. 14, n. 1, p. 44, doi. 10.1007/s10156-007-0574-Z
    By:
    • Shinya Kusachi;
    • Yoshinobu Sumiyama;
    • Jiro Nagao;
    • Yoichi Arima;
    • Yuichi Yoshida;
    • Hidenori Tanaka;
    • Yoichi Nakamura;
    • Yoshihisa Saida;
    • Manabu Watanabe;
    • Ryohei Watanabe;
    • Junko Sato
    Publication type:
    Article
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22

    Effects of luseogliflozin on estimated plasma volume in patients with heart failure with preserved ejection fraction.

    Published in:
    ESC Heart Failure, 2022, v. 9, n. 1, p. 712, doi. 10.1002/ehf2.13683
    By:
    • Nakashima, Mitsutaka;
    • Miyoshi, Toru;
    • Ejiri, Kentaro;
    • Kihara, Hajime;
    • Hata, Yoshiki;
    • Nagano, Toshihiko;
    • Takaishi, Atsushi;
    • Toda, Hironobu;
    • Nanba, Seiji;
    • Nakamura, Yoichi;
    • Akagi, Satoshi;
    • Sakuragi, Satoru;
    • Minagawa, Taro;
    • Kawai, Yusuke;
    • Nishii, Nobuhiro;
    • Fuke, Soichiro;
    • Yoshikawa, Masaki;
    • Nakamura, Kazufumi;
    • Ito, Hiroshi;
    • Namba, Seiji
    Publication type:
    Article
    23
    24

    ANAPHYLAXIS UP-TO-DATE.

    Published in:
    Arerugi: Japanese Journal of Allergology, 2021, v. 70, n. 5, p. 376
    By:
    • Nakamura, Yoichi
    Publication type:
    Article
    25
    26
    27
    28
    29
    30
    31
    32

    A phase II study of amrubicin and carboplatin for previously untreated patients with extensive-disease small cell lung cancer.

    Published in:
    Cancer Chemotherapy & Pharmacology, 2014, v. 74, n. 3, p. 497, doi. 10.1007/s00280-014-2527-4
    By:
    • Ikeda, Takaya;
    • Fukuda, Minoru;
    • Nakamura, Yoichi;
    • Kinoshita, Akitoshi;
    • Senju, Hiroaki;
    • Nakano, Hirofumi;
    • Kitazaki, Takeshi;
    • Ogawara, Daiki;
    • Taniguchi, Hirokazu;
    • Motoshima, Kohei;
    • Yamaguchi, Hiroyuki;
    • Nakatomi, Katsumi;
    • Shimada, Midori;
    • Nagashima, Seiji;
    • Tsukamoto, Kazuhiro;
    • Kohno, Shigeru
    Publication type:
    Article
    33
    34

    Phase II trial of erlotinib in patients with advanced non-small-cell lung cancer harboring epidermal growth factor receptor mutations: additive analysis of pharmacokinetics.

    Published in:
    Cancer Chemotherapy & Pharmacology, 2013, v. 72, n. 6, p. 1299, doi. 10.1007/s00280-013-2307-6
    By:
    • Motoshima, Kohei;
    • Nakamura, Yoichi;
    • Sano, Kazumi;
    • Ikegami, Yoji;
    • Ikeda, Takaya;
    • Mizoguchi, Kosuke;
    • Takemoto, Shinnosuke;
    • Fukuda, Minoru;
    • Nagashima, Seiji;
    • Iida, Tetsuya;
    • Tsukamoto, Kazuhiro;
    • Kohno, Shigeru
    Publication type:
    Article
    35
    36
    37
    38
    39
    40
    41
    42
    43
    44
    45

    Identification of CCDC62-2 as a novel cancer/testis antigen and its immunogenicity.

    Published in:
    International Journal of Cancer, 2009, v. 124, n. 10, p. 2347, doi. 10.1002/ijc.24220
    By:
    • Domae, Shohei;
    • Nakamura, Yoichi;
    • Nakamura, Yurika;
    • Uenaka, Akiko;
    • Wada, Hisashi;
    • Nakata, Masao;
    • Oka, Mikio;
    • Kishimoto, Koji;
    • Tsukamoto, Goichi;
    • Yoshihama, Yasuto;
    • Matsuoka, Junji;
    • Gochi, Akira;
    • Kohno, Shigeru;
    • Saika, Takashi;
    • Sasaki, Akira;
    • Nakayama, Eiichi;
    • Ono, Toshiro
    Publication type:
    Article
    46
    47
    48
    49
    50